Literature DB >> 22184818

How should risks and benefits be balanced in research involving pregnant women and fetuses?

Carson Strong1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22184818      PMCID： PMC3250987     

Source DB:  PubMed          Journal:  IRB        ISSN： 0193-7758


× No keyword cloud information.
  4 in total

Review 1.  In utero gene therapy: current challenges and perspectives.

Authors:  Simon N Waddington; M Gabriela Kramer; Ruben Hernandez-Alcoceba; Suzanne M K Buckley; Michael Themis; Charles Coutelle; Jesus Prieto
Journal:  Mol Ther       Date:  2005-05       Impact factor: 11.454

Review 2.  Fetal surgery is a clinical reality.

Authors:  Jan A Deprest; Roland Devlieger; Kasemsri Srisupundit; Veronika Beck; Inga Sandaite; Silvia Rusconi; Filip Claus; Gunnar Naulaers; Marc Van de Velde; Paul Brady; Koen Devriendt; Joris Vermeesch; Jaan Toelen; Marianne Carlon; Zeger Debyser; Luc De Catte; Liesbeth Lewi
Journal:  Semin Fetal Neonatal Med       Date:  2009-11-13       Impact factor: 3.926

3.  An ethically justified framework for clinical investigation to benefit pregnant and fetal patients.

Authors:  Frank A Chervenak; Laurence B McCullough
Journal:  Am J Bioeth       Date:  2011-05       Impact factor: 11.229

Review 4.  Gaps in knowledge in treating pregnant women.

Authors:  Donald Mattison; Anne Zajicek
Journal:  Gend Med       Date:  2006-09
  4 in total
  3 in total

Review 1.  Ethics of studies of drugs in pregnancy.

Authors:  Doreen Matsui
Journal:  Paediatr Drugs       Date:  2015-02       Impact factor: 3.022

2.  Ethics, regulation, and beyond: the landscape of research with pregnant women.

Authors:  Carla Saenz; Phaik Yeong Cheah; Rieke van der Graaf; Leslie Meltzer Henry; Anna C Mastroianni
Journal:  Reprod Health       Date:  2017-12-14       Impact factor: 3.223

3.  Ethical tensions in the informed consent process for randomized clinical trials in emergency obstetric and newborn care in low and middle-income countries.

Authors:  Dan K Kaye; Gershom Chongwe; Nelson K Sewankambo
Journal:  BMC Med Ethics       Date:  2019-04-27       Impact factor: 2.652
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.